VTYX Stock Rises on Strategic Equity Investment Deal With SNY - Novo Nordisk ( NYSE:NVO ) , Eli Lilly ( NYSE:LLY )
Shares of Ventyx Biosciences VTYX gained 7% on Monday after the company announced that it has entered into a $27 million strategic investment agreement with Sanofi. Per the terms of the deal, Sanofi will buy 70,601 of Ventyx's Series A non-voting convertible preferred stock for $3.8243 per share.
| Ticker |
Sentiment |
Impact |
|
LLY
|
Neutral
|
25 %
|
|
VTYX
|
Bullish
|
25 %
|
|
NVO
|
Neutral
|
25 %
|
|
SNY
|
Somewhat Bullish
|
25 %
|
